MSF Challenges Pfizer Patent Application For Pneumonia Vaccine In India 11/03/2016 by Intellectual Property Watch 1 Comment Today, Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent opposition against Pfizer’s vaccine for pneumonia in India.
ICANN Marrakesh Meeting Reaches Milestone For IANA Transition 11/03/2016 by Monika Ermert for Intellectual Property Watch 2 Comments The Board of the Internet Corporation for Assigned Names and Numbers (ICANN) at its 55th meeting in Marrakesh today (10 March) passed a milestone resolution to ship a package of proposals by its stakeholder groups to the US National Telecommunications and Information Administration (NTIA) to end the latter’s role as an oversight body for the internet. If approved, ICANN will be the next manager of Internet Assigned Numbers Authority (IANA), which is a set of registries for domain names, IP addresses and protocol parameters essential for the functioning of the global internet.
WHO Welcomes UN Secretary-General’s High-Level Panel, Offers Suggestions 10/03/2016 by William New, Intellectual Property Watch Leave a Comment The World Health Organization has provided a list of suggestions to the United Nations Secretary General’s High-Level Panel on Access to Medicines, highlighting WHO activities in this area and making suggestions on areas the WHO has not yet been able to complete. It also describes several new proposals by WHO, including a global “fair pricing forum,” a pooled health product R&D fund, and a global antibiotic research and development facility.
Civil Society Concerns Over US Health Service Plan To Give Exclusive Patent Rights To Sanofi 10/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The United States National Institutes of Health’s decision to consider granting an exclusive licence on patents for a newly government-developed vaccine to Sanofi has prompted a strong reaction from civil society warning against potential high prices and requesting transparency in the process.
Zika Virus R&D: No Vaccine Before 3 To 5 Years, Sample Sharing Needs Incentives 10/03/2016 by Catherine Saez, Intellectual Property Watch 2 Comments International experts convened by the World Health Organization this week on the Zika virus said vaccine development is a priority for the future but the most pressing need is to get diagnostic and prevention tools. Over 60 groups are hard at work on experimental products, according to the WHO, while a system of incentives to share virus samples is being considered.
Governments Agree To ICANN Accountability Proposals, Giving Green Light For IANA Transition 09/03/2016 by Intellectual Property Watch Leave a Comment Governments gathered at the 55th meeting of the Internet Corporation for Assigned Names and Numbers (ICANN) in Marrakesh this week have agreed to not object to the final proposal on enhancing ICANN accountability. By the move, the governments cleared the way to allow a potential handover of the management of the central root zone of the domain name system and other core databases to ICANN from the United States Department of Commerce’s National Telecommunications and Information Administration (NTIA).
Gilead Sovaldi Case Reveals Patent-Health Fissures In India 09/03/2016 by Patralekha Chatterjee for Intellectual Property Watch 2 Comments NEW DELHI — Are patient groups, health activists and manufacturers of low-cost generic drugs always on the same page? Do India’s generic companies think alike? The short answer: not necessarily, though their interests have overlapped on many occasions.
UN Global Dialogue On Innovation And Access To Medicines This Week 08/03/2016 by Intellectual Property Watch Leave a Comment The United Nations Secretary General’s High-Level Panel on Access to Medicines is holding a global dialogue this month, attended by governments, civil society, industry and academia, to discuss potential solutions to promote innovation and at the same time increase access to medicines. The first public dialogue session is this week, on 10 March in London.
WHO: Zika Virus Spreading, R&D Needs Financing, Sample Sharing Discussed 08/03/2016 by Catherine Saez, Intellectual Property Watch 5 Comments The World Health Organization said today that evidence of the relationship between the Zika virus and neonatal malformations and neurological disorders is growing stronger. The Emergency Committee set up by the WHO at a gathering today issued advice to the WHO director general, including warning pregnant women to avoid travelling to Zika infected countries. Meanwhile, discussions are ongoing on the sharing of the samples of the virus, and on the question of benefit-sharing. And a call was made for research and development to intensify.
ICANN Meeting In Marrakesh: More Hiccups On Way To IANA Transition 08/03/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment The 55th meeting of the Internet Corporation for Assigned Names and Numbers (ICANN) in Marrakesh this week is expected to finalise the last proposal necessary for the transition of the Internet Assigned Numbers Authority (IANA), a set of core functions necessary for the running of the internet.